Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
34,304,970
-
Shares change
-
+3,038,594
-
Total reported value, excl. options
-
$740,632,813
-
Value change
-
+$64,825,672
-
Number of buys
-
41
-
Number of sells
-
-39
-
Price
-
$21.59
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2019
98 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q3 2019.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,304,970 shares
of 66,399,673 outstanding shares and own 52% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4,912,306 shares), RA CAPITAL MANAGEMENT, L.P. (3,422,312 shares), JANUS HENDERSON GROUP PLC (3,406,748 shares), MPM ASSET MANAGEMENT LLC (3,074,893 shares), BAKER BROS. ADVISORS LP (2,708,200 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,589,291 shares), BlackRock Inc. (1,939,151 shares), TRV GP, LLC (1,781,437 shares), FEDERATED INVESTORS INC /PA/ (1,465,400 shares), and VANGUARD GROUP INC (1,279,279 shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.